Friday, December 25, 2009

Happy Holidays from Future of Biopharma

We're taking some much needed time off from our coverage of clinical trials, drug delivery and other hot topics in Pharma to celebrate the season with our loved ones. We want to sincerely thank you for your readership, your comments and your participation.

Here are our top posts from 2009:
Merck and Schering-Plough mega-merger to create a company greater than the sum of its parts
Biosimilars: time for an approval pathway in the US
Biosimilars in the EU: delivering the goods?

We'll be back in January with more coverage.

We wish you Happy Holidays!


Share this article with your social network, just click below to share now!


Tuesday, December 22, 2009

Complimentary Web Seminar: Offshoring to Emerging Countries: Navigating Uncertain Waters

Offshoring to Emerging Countries: Navigating Uncertain Waters
Thursday, January 21, 2010
2:00 PM - 3:00 PM EST

About the webinar:
As the biotech and pharma industries come out of the current downturn, sponsors will increasingly look for lower coast, high quality cost solutions to their clinical data needs. Combine this with the ever decreasing availability and high cost of clinical trial patients in the US, and we find we must look to the emerging markets for our patients. Setting up studies in far flung places presents significant challenges to the sponsor and can put him in unfamiliar waters. This webinar will discuss ways in which sponsors might safely explore these markets to generate the clinical data they need efficiently and ethically.

What you will learn:
• Understanding the nuances of the changing regulatory environments in offshore clinical trials to better manage trial risks
• Know your environment: an up-to-date picture of standards in India and China and other regions
• Matching trials to the right country: evaluating trial requirements with different regulatory and environmental factors
• Choosing CRO’s that have credible and substantiated experience in trials with key groups

Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex

Register here.

Presented by:


Share this article with your social network, just click below to share now!


Monday, December 14, 2009

Where would you like to attend Drug Delivery Partnerships 2010?

Even though Drug Delivery Partnerships 2010 is just around the corner, we're beginning to play DDP 2011! We're in Orlando, Florida, this year, but would like your input on where you'd like to attend next year! We invite you to participate in our poll.


This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn or Follow us on Twitter! For more on the Drug Delivery Partnerships event, visit the website: http://bit.ly/6chdrj Download the 2010 Drug Delivery Partnerships Brochure: http://bit.ly/8DRnHv


Share this article with your social network, just click below to share now!


Friday, December 11, 2009

Intercell partners with GlaxoSmithKline for new needle free technology

GlaxoSmithKline is partnering with Intercell, by providing payments in order to partner for a needle free vaccine technology.

Intercell CEO Gerd Zettlmeissl stated:
"This new partnership is combining the forces of Intercell's innovative needle-free vaccination program and technologies with a vaccine leader's strength in development and commercialization. In addition, we can pursue our business strategy of creating significant shareholder value as an independent company whilst continuing to develop one of the most innovative product pipelines in the industry."

Read more here.

This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn or Follow us on Twitter! For more on the Drug Delivery Partnerships event, visit the website: http://bit.ly/6chdrj Download the 2010 Drug Delivery Partnerships Brochure: http://bit.ly/8DRnHv


Share this article with your social network, just click below to share now!


Wednesday, December 9, 2009

Nabi Biopharma to Receive $5M from GSK

MSN Money reports that Nabi Biopharma is to receive a $5 million milestone payment from GlaxoSmithKline Biologicals Co as Nabi Biopharma announces the initiation of a Phase I/II clinical trial for two of the antigens in the PentaStaph vaccine candidate, which is now owned by GlaxoSmithKline Biologicals (GSK). As a result of the initiation of the trial, Nabi is eligible for and has invoiced GSK $5 million for successful completion of this milestone due under the agreement governing Nabi's sale of PentaStaph and related assets to GSK. This milestone payment was contingent on initiation of the Phase I clinical trial for two PentaStaph antigens that target the most virulent toxins produced by the bacteria.

Learn more: Market Report -- In Play (NABI)


Share this article with your social network, just click below to share now!


Tuesday, December 8, 2009

Would you like to guest blog from Drug Delivery Partnerships?

That’s right, we’re offering a few exclusive all-access complimentary passes to Drug Delivery Partnerships – January 25-27, 2010 in Orlando, and you could attend the conference – on us ($3,000+ value). We’re looking for experienced bloggers who are well-versed in drug delivery innovation to begin blogging now and also at this year’s event. In return for your posts, you’ll be able to attend educational sessions and training seminars delivered by industry thought-leaders and Pharma professionals through in-depth case studies featuring the industry experts from leading pharmaceutical companies Sanofi Aventis, GlaxoSmithKline, Merck and Company, CIGNA and more.

To apply to be a guest blogger, simply send your name, title, company and a few writing samples (a link to your blog is recommended) to Jennifer Pereira at jpereira@iirusa.com no later than Wednesday, January 13, 2010. We will review the submissions and contact all winners directly with more details. This opportunity doesn’t come often and we encourage you to apply and join us January in Orlando.

For more information about the event, please follow the links below:

For more on the Drug Delivery Partnerships event, visit the website:
http://bit.ly/6chdrj

Download the 2010 Drug Delivery Partnerships Brochure:


Share this article with your social network, just click below to share now!


Monday, December 7, 2009

A Look Back at Partnerships in Clinical Trials Asia Pacific!

Last week, we held the First Annual Partnerships in Clinical Trials Asia Pacific. At this meeting, we heard from many of the professionals who work closely with the clinical trails in the region, as well as where the expect to see the region to go within the next few years. See some of the sessions here:

Focus on China

Tailoring Outsourcing Strategies for the Asia-Pacific Region – Functional Insourcing

The Sponsor-Site Relationship: Optimizing the CRO Partnership

How partnering with Japan CROs Can Benefit the Global & Asian Drug Development

Regional Regulatory Briefings – What It Takes to Get Your Regional Clinical Trial Going

Accelerating Patient Recruitment and Retention in Clinical Trials


Share this article with your social network, just click below to share now!


Wednesday, December 2, 2009

Today! Complimentary Web Seminar: Explore the latest Drug Delivery Advancements in Solid Dosage Forms through Glide's SDI® Delivery

12-1PM EST

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/707185768
Priority Code: P1578W1TwitterBlog

About the Webinar:
Glide Pharma has developed the Glide SDI (Solid Dose Injector) for injecting drugs and vaccines in a solid dosage form, without the need for a needle. The technology offers many benefits, such as drug stability and controlled release, and is suitable for self-injection of drugs in a home environment. The Glide SDI is patent protected and in clinical trials has been preferred to an injection with a standard needle and syringe.

What you will learn:
• An introduction to the Glide Solid Dose Injector
• The benefits of injecting drugs in a solid dosage form
• The market opportunities for a differentiated drug delivery technology
• The competitive landscape for injection technologies


The seminar will give an overview of the Glide SDI, its benefits and pipeline of product opportunities. Data will be presented demonstrating the utility of the technology together with plans for the commercialization of the Glide SDI. In addition, an overview of the competitive landscape for injection technologies will be provided.


Share this article with your social network, just click below to share now!


Tuesday, December 1, 2009

Reminder Free Web Seminar This Thursday: Leveraging Health: Driving Dividends through Value-Based Reimbursement Designs in More Costly Drug Delivery P

Time/Date: Thu, Dec 3, 2009 2:00 PM - 3:00 PM EST
Register: https://www1.gotomeeting.com/register/215966568
Use priority code P1578W2BlogTwitter

No matter how the reform legislation comes to pass, the ultimate outcomes must focus on health, productivity and economic improvement for the communities we serve. The Center for Health Value Innovation, through a grant from Takeda Pharmaceuticals, has prepared an overview of the levers of value-based design and a coordinated decision matrix for companies to consider as they revise their health plans for 2010 and beyond.

Through a suite of levers focused on prevention and wellness, chronic care management and care delivery, plan sponsors of all sizes, self-insured and fully-insured, can identify plan designs, incentives and disincentives that will shift populations to better health behaviors. How the plan sponsor chooses, and what questions are asked, is detailed in a forthcoming report. This webinar will frame the decisions and timelines for dividends in their companies and their communities.

What you will learn:
a. What levers will drive better engagement of the consumer, the plan sponsor and the delivery system and result in improved outcomes?
b. Where do we start? What if we are fully insured and cannot get integrated data—what do we do? What if we are a public entity, or working with unions, or operating under legislative barriers—is value based design still possible?
c. What are reasonable expectations? What are the timelines for achievement and key messages for the C-Suite?
d. How do we work with our vendors and health plans to promote, engage, and measure the outcomes?


Share this article with your social network, just click below to share now!